Skip to main content

03-06-2020 | ASCO 2020 | Conference coverage | Video

Expert comment: The JAVELIN Bladder 100 study

Elizabeth Plimack tells us why the avelumab switch maintenance strategy trialled in JAVELIN Bladder 100 could be a game changer for the field of advanced urothelial cancer (3:51).

Read transcript

Have your say on Medicine Matters

Visit the conference hub

Image Credits